Serum Challenges EMA100 (18% to 64% Targets)

28 ביוני 2022

SRMBTC (Serum) is challenging EMA100 right now.

Breaking above this leave can lead to straight up.

We can see a clear rejection at EMA100 on 26-June, yet this level is being challenged again today.

With strong indicators, it is likely that this resistance will break.

First, we have an 18% target, very easy, followed by 64%.

More details on the chart.

Namaste.